Goldman Analyst during Mylan Q&A just said Novartis has yet to launch Copaxone 40 mg? If that is the case, what is driving this company higher to new 52 week highs? Novel Drug updates are still months away, FOB Humira sale cannot be that big of a deal. Something major is being discounted, I am sure we all will find out shortly. Stock has made a nice 40% pop over the last year and I am not complaining..
Market Data 
Markets 
AI
